Sign Out
Solifenacin is contraindicated in patients with urinary retention, severe gastro-intestinal condition (including toxic megacolon), myasthenia gravis or narrow-angle glaucoma and in patients at risk for these conditions.
Patients hypersensitive to the active substance or to any of the excipients.
Patients undergoing hemodialysis.
Patients with severe hepatic impairment.
Patients with severe renal impairment or moderate hepatic impairment and who are on treatment with a potent CYP3A4 inhibitor, e.g. Ketoconazole.
